Imaging brain metastases of prostate cancer with 68Ga-PSMA PET/MRI: Two case reports

Abstract

Brain metastasis in prostate cancer is a rare entity with a poor prognosis. Early detection of brain metastasis might improve patient management and prognosis. 68-Gallium prostate-specific membrane antigen (68Ga-PSMA) positron emission tomography/magnetic resonance imaging (PET/MRI) is a unique imaging modality for prostate cancer patients with higher accuracy and soft tissue resolution, which provides excellent identification of soft tissue metastases. We have presented two prostate adenocarcinoma patients with unexpected brain metastases demonstrated by 68Ga-PSMA PET/MRI.